Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx.
Kalpakoff M, Hund S, Musser J, Roach C, Apostolaki A, Vilardo M, Peltz L, Watts B, LaPlaca C, Tabuena-Frolli S, DiMaio MA, Welcher R, Kulangara K. Kalpakoff M, et al. Among authors: tabuena frolli s. Appl Immunohistochem Mol Morphol. 2021 Oct 1;29(9):667-673. doi: 10.1097/PAI.0000000000000941. Appl Immunohistochem Mol Morphol. 2021. PMID: 33973887 Free PMC article.
A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone.
Polewski MD, Nielsen GB, Gu Y, Weaver AT, Gegg G, Tabuena-Frolli S, Cajaiba M, Hanks D, Method M, Press MF, Gottstein C, Gruver AM. Polewski MD, et al. Among authors: tabuena frolli s. Appl Immunohistochem Mol Morphol. 2022 Apr 1;30(4):237-245. doi: 10.1097/PAI.0000000000001009. Appl Immunohistochem Mol Morphol. 2022. PMID: 35384873 Free PMC article. Clinical Trial.